Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.
Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.
The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. In Among all European countries, Spain, Italy, Germany, France, and UK are most affected due to increasing number of coronavirus cases and deaths associated with it. As per the news article, in Italy, due to Covid-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants and surgery has become difficult. According to the research led by Codice Viola, charity that supports pancreatic cancer patients found that more than 500 breast or pancreatic patients’ appointments for chemotherapy or radiotherapy were postponed. Additionally, 64% of surgical procedures were postponed and more than half have had follow-up appointments rescheduled. The Covid-19 pandemic has challenged hard the national health systems worldwide. According to the national policy issued in March 2020 in response to the evolving Covid-19 pandemic, several hospitals were re-configured as Covid-19 centers and elective surgery procedures were rescheduled according to the most recent recommendations. In addition, Covid-19 protected cancer hubs were established, including the Regina Elena National Cancer Institute of Rome, Central Italy.
Strategic insights for the Europe Breast Reconstruction provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 135.8 Million |
Market Size by 2028 | US$ 197.2 Million |
Global CAGR (2021 - 2028) | 5.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Technology
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Breast Reconstruction refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Breast reconstruction market in Europe is expected to grow from US$ 135.8 million in 2021 to US$ 197.2 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. The surgeons performing implant-breast reconstruction procedures face various challenges in terms of providing sufficient soft tissue coverage and support to implant, defining a natural breast shape, avoiding problems related to contracture, and so on, which act as hindrance in achieving optimum results. However, the adoption of ADM in the recent years has helped them overcome the aforementioned issues. ADM is a soft tissue substitute derived from donated human skin tissue. The tissue undergoes a multi-step proprietary process to avoid chances of rejection, which mainly involves removing cells that can cause antigenic response in the receiver’s body. The use of ADM also helps skip skin grafting procedure and harvesting tissues from one’s own body, which acts as an advantage for the patients as well as healthcare providers. Moreover, these matrices are available in different shapes, sizes, and thicknesses to meet the specific needs of the patients.
In terms of technology, the inframammary segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.
A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc
By Technology
By Type
By Placement
By Procedure
By Country
The Europe Breast Reconstruction Market is valued at US$ 135.8 Million in 2021, it is projected to reach US$ 197.2 Million by 2028.
As per our report Europe Breast Reconstruction Market, the market size is valued at US$ 135.8 Million in 2021, projecting it to reach US$ 197.2 Million by 2028. This translates to a CAGR of approximately 5.5% during the forecast period.
The Europe Breast Reconstruction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Breast Reconstruction Market report:
The Europe Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Breast Reconstruction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.